Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Board Committee Changes

29 Jul 2016 16:45

RNS Number : 7403F
Reckitt Benckiser Group PLC
29 July 2016
 

29 July 2016

RECKITT BENCKISER GROUP PLC

(The "Company" or "RB")

 

BOARD COMMITTEE CHANGES

 

The Company is pleased to announce the following changes to its standing Board Committees and their membership.

New Corporate Responsibility, Sustainability, Ethics and Compliance Committee

On the recommendation of the Nomination Committee, on 28 July 2016 the Board approved the establishment of a new Board committee to be known as the Corporate Responsibility, Sustainability, Ethics and Compliance Committee ("CRSEC Committee") with immediate effect. This new committee will support the Board in fulfilling its duty to safeguard and advance the Company's reputation for responsible and sustainable corporate conduct by reviewing, monitoring and assessing its approach to and management of corporate social responsibility, environmental and sustainability issues and behaviours, ethical conduct and regulatory compliance.

The CRSEC Committee will be chaired by Pam Kirby, and Adrian Bellamy and Nicandro Durante have been appointed as committee members. The CRSEC Committee will meet at least three times per year and at such other times as required. 

The Committee's terms of reference will be available on the Company's website at www.rb.com

Nomination Committee Membership

The Nomination Committee also recommended, and the Board approved, the appointment of Pam Kirby to the Nomination Committee with immediate effect. 

This disclosure is made in accordance with paragraph 9.6.11 of the Financial Conduct Authority's Listing rules.

 

For further Information:

Chris LoganCompany Secretary+44 (0) 1753 217 800

 

Richard Joyce

SVP, Investor Relations, Communications & External Affairs

+44 (0)1753 217 800

 

 

About RB:

 

RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately c. 37,000 people worldwide.

Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.

 

RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea. 

 

For more information visit www.rb.com

 

*RB is the trading name of the Reckitt Benckiser group of companies

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASEEFIUFMSELW
Date   Source Headline
14th Nov 20145:33 pmRNSShare repurchase
13th Nov 20145:38 pmRNSShare repurchase
12th Nov 20145:53 pmRNSShare repurchase
11th Nov 20145:05 pmRNSShare repurchase
10th Nov 20145:05 pmRNSShare repurchase
7th Nov 20144:58 pmRNSShare repuchase
6th Nov 20145:18 pmRNSShare repurchase
5th Nov 20145:06 pmRNSShare repurchase
4th Nov 20144:54 pmRNSShare repurchase
3rd Nov 20145:05 pmRNSShare repurchase
31st Oct 20145:24 pmRNSTotal Voting Rights
31st Oct 20145:10 pmRNSShare repurchase
30th Oct 20145:34 pmRNSShare repurchase
29th Oct 20145:15 pmRNSShare repurchase
28th Oct 20145:00 pmRNSShare repurchase
28th Oct 201412:00 pmRNSDirectorate Change
27th Oct 20145:07 pmRNSShare repurchase
24th Oct 20145:01 pmRNSTransaction in Own Shares
21st Oct 20147:00 amRNSQ3 Interim Management Statement
14th Oct 20145:59 pmRNSShare repurchase
13th Oct 20144:52 pmRNSShare repurchase
10th Oct 20145:12 pmRNSShare repurchase
9th Oct 20145:01 pmRNSShare repurchase
8th Oct 20144:59 pmRNSShare repurchase
7th Oct 20144:59 pmRNSShare repurchase
6th Oct 20145:13 pmRNSShare repurchase
3rd Oct 20145:55 pmRNSDirector/PDMR Shareholding
3rd Oct 20144:50 pmRNSShare repurchase
2nd Oct 20145:09 pmRNSShare repurchase
1st Oct 20144:59 pmRNSShare repurchase
30th Sep 20144:56 pmRNSTotal Voting Rights
30th Sep 20144:51 pmRNSShare repurchase
30th Sep 201410:53 amRNSDirectorate Change
29th Sep 20145:00 pmRNSShare repurchase
29th Sep 201411:08 amRNSDirector/PDMR Shareholding
29th Sep 201411:04 amRNSDirector/PDMR Shareholding
29th Sep 201411:02 amRNSDirector/PDMR Shareholding
29th Sep 201411:00 amRNSDirector/PDMR Shareholding
26th Sep 20145:08 pmRNSShare repurchase
25th Sep 20145:02 pmRNSTransaction in Own Shares
24th Sep 20145:18 pmRNSShare repurchase
23rd Sep 20144:54 pmRNSShare repurchase
22nd Sep 20144:51 pmRNSShare repurchase
22nd Sep 201410:42 amRNSDirector/PDMR Shareholding
22nd Sep 201410:34 amRNSDirector/PDMR Shareholding
22nd Sep 201410:32 amRNSDirector/PDMR Shareholding
19th Sep 20144:56 pmRNSShare repurchase
18th Sep 20145:20 pmRNSShare repurchase
17th Sep 20145:16 pmRNSShare repurchase
16th Sep 20144:54 pmRNSShare repurchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.